Rebutting the implied-preemption defense: in products suits, drug companies are seeking immunity under theories of implied preemption. Their arguments are flawed.: An article from: Trial

This digital document is an article from Trial, published by Association of Trial Lawyers of America on November 1, 2003. The length of the article is 4412 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Rebutting the implied-preemption defense: in products suits, drug companies are seeking immunity under theories of implied preemption. Their arguments are flawed.
Author: Allison M. Zieve
Publication:Trial (Magazine/Journal)
Date: November 1, 2003
Publisher: Association of Trial Lawyers of America
Volume: 39 Issue: 12 Page: 46(6)

Distributed by Thomson Gale